Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1937 - 1944 of 11454 results
President Says Russia “Exploring” Cyberattacks Against U.S.
March 21, 2022| Blog| Viewpoint
Green Deals Tripled Last Year Amid Emissions Crunch
March 21, 2022| News
TCPA Litigation Update — No Deference to the FCC’s 2006 Fax Order
March 21, 2022| Article| Viewpoint
New York State HERO Act Designation Expires
March 21, 2022| Blog| Viewpoint
Could A Bored Ape + CryptoPunk + ApeCoin = A Security?
March 18, 2022| Article| Viewpoint
Connecticut Proposal to Cap Drug Price Increases Could Portend a Shift in the Drug Pricing Debate
March 17, 2022| Blog| Viewpoint
Utah Consumer Privacy Act – Mintz’s Hot Take
March 17, 2022| Blog| Viewpoint
Meet Healey’s New Campaign Manager
March 17, 2022| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.